Literature DB >> 11223550

Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification.

H Kobayashi1, M Higashiyama, K Minamigawa, K Tanisaka, T Takano, H Yokouchi, K Kodama, T Hata.   

Abstract

To develop a simpler method of performing the collagen gel droplet-embedded culture drug sensitivity test (CD-DST), we examined the introduction of colorimetric quantitative determination of images for evaluation of anticancer effect against cancer cells alone in the presence of fibroblasts, based on differences in proliferative morphology and stainability with neutral red of cells within collagen gel drops determined using a video-microscope and NIH Image software. In examinations using a human cancer cell line and a fibroblast cell line, a high degree of linearity between number of cancer cells and image-optical density was found within the range of 10(2) - 10( 6) cells / droplet (r (2) = 0.933). Using NIH Image, fibroblast cells could be eliminated at a cut-off value of 128, and an immunocytochemical method demonstrated that the cells eliminated from the image were indeed fibroblasts, and those remaining were cancer cells. CD-DST was carried out with mixtures of cancer cells with fibroblasts at various ratios, and the feasibility of evaluating anticancer activity in cancer cells alone with no effect of fibroblasts at any mixing ratio was confirmed. In addition, for CD-DST of primary cell cultures of human lung cancers collected at the time of surgery, a high correlation between results obtained with the volume supplementation method, a current cell quantification method, and those with the imaging colorimetric quantification method was obtained (r = 0.933). These results indicate that introduction of imaging colorimetric quantification utilizing NIH Image makes CD-DST a quick and simple method that should be highly useful for clinical chemosensitivity testing using primary cell cultures of human cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223550      PMCID: PMC5926701          DOI: 10.1111/j.1349-7006.2001.tb01083.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  32 in total

1.  Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.

Authors:  T Furukawa; T Kubota; M Watanabe; S Kase; T Takahara; H Yamaguchi; T Takeuchi; T Teramoto; K Ishibiki; M Kitajima
Journal:  Anticancer Res       Date:  1992 Sep-Oct       Impact factor: 2.480

2.  Drug sensitivity test for primary culture of human cancer-cells using collagen gel embedded culture and image-analysis.

Authors:  M Koezuka; N Kondo; H Kobayashi; S Hara; M Yasutomi; S Nishida; S Hashimoto; H Asano
Journal:  Int J Oncol       Date:  1993-06       Impact factor: 5.650

3.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

4.  Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors.

Authors:  D H Kern; C R Drogemuller; M C Kennedy; S U Hildebrand-Zanki; N Tanigawa; V K Sondak
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

5.  Significance of three-dimensional growth patterns of mammary tissues in collagen gels.

Authors:  E M Lawler; F R Miller; G H Heppner
Journal:  In Vitro       Date:  1983-08

6.  Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs.

Authors:  M Higashiyama; K Kodama; H Yokouchi; K Takami; O Doi; H Kobayashi; K Tanisaka; K Minamigawa
Journal:  J Surg Oncol       Date:  1998-05       Impact factor: 3.454

7.  A general native-state method for determination of proliferation capacity of human normal and tumor tissues in vitro.

Authors:  R M Hoffman; K M Connors; A Z Meerson-Monosov; H Herrera; J H Price
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Human tumor cloning: feasibility and clinical correlations.

Authors:  D D Von Hoff; J Cowan; G Harris; G Reisdorf
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

9.  In vivo-like growth of human tumors in vitro.

Authors:  A E Freeman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  20 in total

1.  Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively.

Authors:  Kentaro Maejima; Akira Tokunaga; Teruo Kiyama; Hitoshi Kanno; Hideki Bou; Masanori Watanabe; Hideyuki Suzuki; Eiji Uchida
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

2.  Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST).

Authors:  Masahiko Higashiyama; Jiro Okami; Jun Maeda; Toshiteru Tokunaga; Ayako Fujiwara; Ken Kodama; Fumio Imamura; Hisayuki Kobayashi
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

3.  Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Tadasuke Hashiguchi; Akinori Nakatani; Takashi Marusasa; Akira Muraki; Isao Nagaoka; Shunji Futagawa
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

4.  Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil.

Authors:  Kaname Sakuma; Akira Tanaka; Izumi Mataga
Journal:  Oncol Lett       Date:  2016-10-11       Impact factor: 2.967

5.  Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas.

Authors:  Takako Nakahara; Toshiyuki Sakaeda; Tsutomu Nakamura; Takao Tamura; Chiharu Nishioka; Nobuo Aoyama; Noboru Okamura; Toshiro Shirakawa; Akinobu Gotoh; Takashi Kamigaki; Masakazu Ohno; Yoshikazu Kuroda; Masafumi Matsuo; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

6.  Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Akinori Nakatani; Kiichi Nagayasu; Shigetoshi Naito; Tsuyoshi Sato; Kenji Kishine; Yu Abe; Chihiro Hara; Susumu Yamada; Satomi Mashiko; Isao Nagaoka
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

7.  Three-dimensional cellular microarray for high-throughput toxicology assays.

Authors:  Moo-Yeal Lee; R Anand Kumar; Sumitra M Sukumaran; Michael G Hogg; Douglas S Clark; Jonathan S Dordick
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-26       Impact factor: 11.205

8.  Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer.

Authors:  Yoshimasa Inoue; Hozumi Matsumoto; Shunsuke Yamada; Kenji Kawai; Hiroshi Suemizu; Masatoshi Gika; Iwao Takanami; Masayuki Iwazaki; Masato Nakamura
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

9.  Synovial sarcoma individual chemotherapy directed by collagen gel droplet embedded culture drug sensitivity test: A case report.

Authors:  Feng Gu; Yongjie Ma; Yu Fan; Ronggang Lang; Ting Ding; Xishan Hao; Yun Gong; Hisayuki Kobayahsi; Zhiwei Fang; Li Fu
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

10.  Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Akinori Nakatani; Takashi Inou; Marie Washio; Naoki Sakuyama; Tsuyoshi Sato; Kenji Kishine; Takanori Ochi; Satoshi Okubo; Shunji Futagawa; Satomi Mashiko; Isao Nagaoka
Journal:  Oncol Lett       Date:  2012-07-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.